Literature DB >> 15665590

Association of the XRCC1 gene polymorphisms with cancer risk in Turkish breast cancer patients.

Ugur Deligezer1, Nejat Dalay.   

Abstract

The X-ray repair cross-complementing group 1 (XRCC1) gene is believed to play an important role in base excision repair and displays genetic polymorphisms. Data on the role of XRCC1 polymorphisms in cancer susceptibility is inconsistent. In the present study, we investigated the effect of two XRCC1 polymorphisms, Arg194Trp and Arg399Gln, on breast cancer risk in a case- control study involving Turkish breast cancer patients and healthy women. Both alleles exhibited a similar distribution among cases and controls leading to lack of any significant association between the XRCC1 polymorphisms and breast cancer risk, either in homozygotes and heterozygotes or combined. The allele frequency of the codon 194 variant was very low in cases and healthy individuals (5.3 and 3.9%, respectively) compared to that of the variant 399Gln allele (39.7 and 37.4%). Our results do not support evidence for a role of the XRCC1 polymorphism in developing breast cancer.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15665590     DOI: 10.1038/emm.2004.73

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  15 in total

1.  First survey of the two polymorphisms (Arg194Trp and Arg399Gln) in XRCC1 gene in four Afghanistan populations and comparison with worldwide data.

Authors:  Khyber Saify; Iraj Saadat; Mostafa Saadat
Journal:  Mol Biol Rep       Date:  2013-05-22       Impact factor: 2.316

2.  Association between the XRCC1 Arg194Trp polymorphism and risk of cancer: evidence from 201 case-control studies.

Authors:  Yan-Zhong Feng; Yi-Ling Liu; Xiao-Feng He; Wu Wei; Xu-Liang Shen; Dao-Lin Xie
Journal:  Tumour Biol       Date:  2014-07-27

3.  Impact of DNA repair genes polymorphism (XPD and XRCC1) on the risk of breast cancer in Egyptian female patients.

Authors:  Yousry Mostafa Hussien; Amal F Gharib; Hanan A Awad; Rehab A Karam; Wael H Elsawy
Journal:  Mol Biol Rep       Date:  2011-06-05       Impact factor: 2.316

4.  Polymorphisms of the XRCC1 gene and breast cancer risk in the Mexican population.

Authors:  Nelly M Macías-Gómez; Valeria Peralta-Leal; Juan Pablo Meza-Espinoza; Melva Gutiérrez-Angulo; Jorge Durán-González; Juan Manuel Ramírez-González; Alejandra Gaspar-Del Toro; Adolfo Norberto-Rodríguez; Evelia Leal-Ugarte
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

5.  Genetic polymorphisms of XRCC1 (at codons 194 and 399) in Shiraz population (Fars province, southern Iran).

Authors:  Parisa Mohamadynejad; Mostafa Saadat
Journal:  Mol Biol Rep       Date:  2007-09-14       Impact factor: 2.316

6.  Contribution of XPD (Lys751Gln) and XRCC1 (Arg399Gln) polymorphisms in familial and sporadic breast cancer predisposition and survival: an Indian report.

Authors:  Volga S Syamala; Vani Syamala; Hariharan Sreedharan; Praveenkumar B Raveendran; Ratheesan Kuttan; Ravindran Ankathil
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

7.  XRCC1 gene polymorphisms in a population sample and in women with a family history of breast cancer from Rio de Janeiro (Brazil).

Authors:  Priscila Falagan-Lotsch; Marina S Rodrigues; Viviane Esteves; Roberto Vieira; Luis C Amendola; Dante Pagnoncelli; Júlio C Paixão; Claudia V De Moura Gallo
Journal:  Genet Mol Biol       Date:  2009-06-01       Impact factor: 1.771

8.  Investigation on XRCC1 genetic polymorphism and its relationship with breast cancer risk factors in Chinese women.

Authors:  Luming Zheng; Feng Yang; Xukui Zhang; Jian Zhu; Pen Zhou; Fang Yu; Lei Hou; Guowei Zhao; Qingqing He; Baocheng Wang
Journal:  Med Oncol       Date:  2013-10-25       Impact factor: 3.064

9.  TP53 and XRCC1 polymorphisms and breast cancer prognosis: a case-case study.

Authors:  Marina Silva Rodrigues; Camila Almeida Machado; Dante Pagnoncelli; Elizabeth Avvad; Júlio César da Paixão; Claudia Vitoria de Moura Gallo
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

10.  A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.

Authors:  Alpa V Patel; Eugenia E Calle; Alexandre L Pavluck; Heather Spencer Feigelson; Michael J Thun; Carmen Rodriguez
Journal:  Breast Cancer Res       Date:  2005-11-21       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.